This product is intended for research use only and is not to be used for unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses, or any type of consumption or application to humans or animals. This product is soluble in DMSO and insoluble in water. Stability once in solution has not been tested in-house. Other sources do not recommend storing the aqueous solution for more than one day.
すべての画像(1)
サイズを選択してください
表示を変更する
25 MG
￥63,100
About This Item
実験式（ヒル表記法）:
C22H36ClNO · xH2O
CAS番号:
分子量:
365.98 (anhydrous basis)
MDL番号:
UNSPSCコード:
51111800
PubChem Substance ID:
NACRES:
NA.77
おすすめの製品
品質水準
アッセイ
≥97% (HPLC)
フォーム
oil
薬剤管理
regulated under CDSA - not available from Sigma-Aldrich Canada
保管条件
desiccated
色
brown-red
溶解性
DMSO: soluble
H2O: insoluble
保管温度
−20°C
SMILES記法
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl
InChI
1S/C22H36ClNO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15-
InChI Key
SCJNCDSAIRBRIA-DOFZRALJSA-N
遺伝子情報
mouse ... Cnr1(12801) , Cnr2(12802)
rat ... Cnr1(25248)
生物化学的／生理学的作用
神経細胞のCB1カンナビノイドレセプタ-に対する強力かつ選択的なアゴニストです。
特徴および利点
This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
注意
光に不安定です。また、アルゴンか窒素ガスで置換して保存して下さい。
保管分類コード
10 - Combustible liquids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
個人用保護具 (PPE)
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
A9719-IP:
A9719-25MG:
A9719-VAR:
A9719-25MG-PW:
A9719-BULK-PW:
A9719-100MG:
A9719-100MG-PW:
A9719-BULK:
この製品を見ている人はこちらもチェック
Yahya I Asiri et al.
Anesthesia and analgesia, 127(2), 548-555 (2017-10-11)
Development of new analgesics is limited by shortcomings of existing preclinical screening assays such as wide variations in response, suitability for a narrow range of analgesics, and propensity to induce tissue damage. Our aim was to determine the feasibility of
Kristina B V Døssing et al.
Genes, 9(7) (2018-07-06)
Somatostatin (SST) analogues are used to control the proliferation and symptoms of neuroendocrine tumors (NETs). MicroRNAs (miRNA) are small non-coding RNAs that modulate posttranscriptional gene expression. We wanted to characterize the miRNAs operating under the control of SST to elucidate
Akiko Tsuchida et al.
Scientific reports, 8(1), 7017-7017 (2018-05-08)
GalNAc-disialyl Lc4 (GalNAc-DSLc4) was reported as a novel antigen that associated with malignant features of renal cell cancers (RCCs). To clarify roles of GalNAc-DSLc4 in malignant properties of RCCs, we identified B4GalNAc-T2 as a responsible gene for the synthesis of
Chris L Baker et al.
British journal of pharmacology, 142(8), 1361-1367 (2004-07-28)
The vasoactive effects of the synthetic cannabinoid (CB) arachidonyl-2-chloroethylamide (ACEA) was tested in the knee joints of urethane-anaesthetised rats. Experiments were also performed to determine whether these vasomotor responses could be blocked by the selective CB(1) receptor antagonists AM251 (N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide)
C J Hillard et al.
The Journal of pharmacology and experimental therapeutics, 289(3), 1427-1433 (1999-05-21)
Two subtypes of the cannabinoid receptor (CB1 and CB2) are expressed in mammalian tissues. Although selective antagonists are available for each of the subtypes, most of the available cannabinoid agonists bind to both CB1 and CB2 with similar affinities. We
アクティブなフィルタ
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）
